1. Glenmark Life Science
stock logo

75% Buy

Glenmark Life Science Share Price

GLS

₹848.30+₹6.15 (0.73%) TodayLast updated on 12 Jul, 2024 | 03:59 PM IST
₹837.50₹866.90
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹10,394 Crs

Open

₹838.00

Close

₹842.15

Circuit range

₹933.10 - ₹763.50

Day range

₹837.50 - ₹866.90

Year range

₹581.10 - ₹972.00

Volume

12,25,612

Avg. traded

₹848.62

Revenue (12m)

₹2,283 Crs

Glenmark Life ScienceGlenmark Life Sciences Limited is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). It also develops APIs in the therapeutic areas such as anti-fungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. It has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed capacity of approximately 1198 KL.

Glenmark Life Science Key indicators

arrow

52 week high

₹972.00

52 week low

₹581.10

P/E ratio

22.1

P/B ratio

4.46

ROE

22.33%

ROCE

30.01%

Dividend yield

2.65%

Debt/Equity ratio

EPS

38.11

Learn more

Investment checklist: (5/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

75%

Hold

25%

Sell

0%

This analysis is based on the reviews of 4 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

30.89%

Net profit margin

21.49%

ROE

22.33%

ROA

15.43%

ROCE

30.01%

Learn more

Glenmark Life Science Shareholder returns

arrow

1 day

+0.73%

1 week

-6.61%

1 month

-1.82%

3 months

+4.87%

1 year

+42.62%

3 years

+13.33%

5 years

+13.33%

Glenmark Life Science Share Price history

arrow
DayOpenCloseDay’s change
Fri, Jul 12 2024
₹838.00
₹848.30
+0.73%
Thu, Jul 11 2024
₹847.60
₹842.15
-3.85%
Wed, Jul 10 2024
₹889.05
₹875.85
-1.48%
Tue, Jul 9 2024
₹893.00
₹889.05
+0.30%
Mon, Jul 8 2024
₹907.95
₹886.35
-2.42%
Fri, Jul 5 2024
₹912.00
₹908.35
-0.37%
Thu, Jul 4 2024
₹935.00
₹911.70
-1.48%
Wed, Jul 3 2024
₹882.00
₹925.35
+4.59%

Shareholding info

arrow

Promoters (82.85%)

Mutual Funds (0.93%)

Retail and other (10.73%)

Foreign institutions-FII (5.01%)

Other domestic institutions (0.47%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹22.5/share

    Ex date 17 Oct 2023

    expand tab
  • Dividend • ₹21/share

    Ex date 24 Mar 2023

    expand tab
  • Dividend • ₹10.5/share

    Ex date 15 Sep 2022

    expand tab
  • Dividend • ₹10.5/share

    Ex date 22 Nov 2021

    expand tab

Learn more

Frequently asked questions